Evidence map›Paper›PMID 26554718›Full record

ArticleBMC bioinformatics2015

QQ-SNV: single nucleotide variant detection at low frequency by comparing the quality quantiles.

Koen Van der Borght, Kim Thys, Yves Wetzels, Lieven Clement, Bie Verbist, Joke Reumers, Herman van Vlijmen, Jeroen Aerssens

Abstract readComparative Study
In one paragraph

Article in BMC bioinformatics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Koen Van der BorghtJanssen Infectious Diseases-Diagnostics BVBA, B-2340, Beerse, Belgium. kvdborgh@its.jnj.com.
Kim ThysJanssen Infectious Diseases-Diagnostics BVBA, B-2340, Beerse, Belgium. kthys@its.jnj.com.
Yves WetzelsJanssen Infectious Diseases-Diagnostics BVBA, B-2340, Beerse, Belgium. ywetzel@its.jnj.com.
Lieven ClementGhent University, Applied Mathematics, Informatics and Statistics, B-9000, Ghent, Belgium. lieven.clement@ugent.be.
Bie VerbistJanssen Infectious Diseases-Diagnostics BVBA, B-2340, Beerse, Belgium. bverbis2@its.jnj.com.
Joke ReumersJanssen Infectious Diseases-Diagnostics BVBA, B-2340, Beerse, Belgium. jreumers@its.jnj.com.
Herman van VlijmenJanssen Infectious Diseases-Diagnostics BVBA, B-2340, Beerse, Belgium. hvvlijme@its.jnj.com.
Jeroen AerssensJanssen Infectious Diseases-Diagnostics BVBA, B-2340, Beerse, Belgium. jaerssen@its.jnj.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNext generation sequencing enables studying heterogeneous populations of viral infections. When the sequencing is done at high coverage depth ("deep sequencing"), low frequency variants can be detected. Here we present QQ-SNV (http://sourceforge.net/projects/qqsnv), a logistic regression classifier model developed for the Illumina sequencing platforms that uses the quantiles of the quality scores, to distinguish true single nucleotide variants from sequencing errors based on the estimated SNV probability. To train the model, we created a dataset of an in silico mixture of five HIV-1 plasmids. Testing of our method in comparison to the existing methods LoFreq, ShoRAH, and V-Phaser 2 was performed on two HIV and four HCV plasmid mixture datasets and one influenza H1N1 clinical dataset.

resultsFor default application of QQ-SNV, variants were called using a SNV probability cutoff of 0.5 (QQ-SNV(D)). To improve the sensitivity we used a SNV probability cutoff of 0.0001 (QQ-SNV(HS)). To also increase specificity, SNVs called were overruled when their frequency was below the 80(th) percentile calculated on the distribution of error frequencies (QQ-SNV(HS-P80)). When comparing QQ-SNV versus the other methods on the plasmid mixture test sets, QQ-SNV(D) performed similarly to the existing approaches. QQ-SNV(HS) was more sensitive on all test sets but with more false positives. QQ-SNV(HS-P80) was found to be the most accurate method over all test sets by balancing sensitivity and specificity. When applied to a paired-end HCV sequencing study, with lowest spiked-in true frequency of 0.5%, QQ-SNV(HS-P80) revealed a sensitivity of 100% (vs. 40-60% for the existing methods) and a specificity of 100% (vs. 98.0-99.7% for the existing methods). In addition, QQ-SNV required the least overall computation time to process the test sets. Finally, when testing on a clinical sample, four putative true variants with frequency below 0.5% were consistently detected by QQ-SNV(HS-P80) from different generations of Illumina sequencers.

conclusionsWe developed and successfully evaluated a novel method, called QQ-SNV, for highly efficient single nucleotide variant calling on Illumina deep sequencing virology data.

Indexed as

SoftwareAlgorithmsCluster AnalysisComputer SimulationGenome, ViralHepacivirusHepatitis CHigh-Throughput Nucleotide SequencingHIV-1HIV InfectionsHumansPlasmidsPolymorphism, Single NucleotideRegression Analysis

Identifiers

PMID26554718
PMCPMC4641353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.